Traditional medical clinics feel disconnected and do not seek to actually treat Alzheimer's, but simply prescribe medication to mask symptoms. Dr. Kellman has helped countless patients with his functional medicine approach.
Alzheimer's is not confined to the brain. Vascular health, insulin signaling, inflammation, immune function, nutrient status, and the microbiome all shape its trajectory.
Treating it as a single-organ disease with a single-mechanism drug leaves most of those contributors untouched.
Dr. Kellman's reputation is built on the Microbiome Breakthrough, a model that views gut and brain as one interconnected ecosystem. Inflammation, immune imbalance, nutrient deficiency, hormone disruption, and microbiome dysfunction can each accelerate cognitive decline.
Care is deeply personalized: identify and remove the triggers, then nourish the systems that allow the brain to heal and adapt. Patients often report improvements in clarity, mood, and resilience.
Medication addresses neurotransmitter signaling. It does not address inflammation, insulin resistance, nutrient status, or microbiome disruption. Dr. Kellman's work targets those modifiable contributors alongside conventional care.
As early as concern arises. The modifiable drivers of cognitive decline are easier to influence before substantial loss has occurred, which is why Dr. Kellman evaluates patients with mild changes rather than waiting for a formal diagnosis.